Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: A preliminary open-label trial

Psychogeriatrics

Volumn 15, Issue 1, 2015, Pages 32-37

  Suzuki, Hidenobu ^a   Gen, Keishi ^b  

^a Suzuki Clinic   (Japan)

^b Seimo Hospital   (Japan)

Author keywords

Alzheimer's disease; Behavioural and psychological symptoms of dementia; Lamotrigine; Psychotropic drugs

Indexed keywords

DIAZEPAM; LAMOTRIGINE; RISPERIDONE; PSYCHOTROPIC AGENT; TRIAZINE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ANXIETY; ARTICLE; ASSESSMENT OF HUMANS; BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA; COGNITION; CONTROLLED STUDY; DEMENTIA; DRESS SYNDROME; DRUG EFFICACY; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALAISE; MALE; MINI MENTAL STATE EXAMINATION; NAUSEA; NEUROPSYCHIATRIC INVENTORY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RASH; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SYMPTOM; TOXIC EPIDERMAL NECROLYSIS; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; MENTAL DISORDERS; MENTAL HEALTH; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MENTAL STATUS SCHEDULE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; TRIAZINES;

EID: 84924811889     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/psyg.12085     Document Type: Article

References (26)

1. Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8: 497-500.
2. Obeso JA, Martinez-Lage JM. Anticholinergics and amantadine. In: Koller WC, ed. Handbook of Parkinson's Disease. New York: Marcel Dekker, 1987; 309-316.
3. Meltzer HM, Casey DE, Garver DL etal. Evaluating the effects of antipsychotics on cognition in schizophrenia. J Clin Psychiatry 1998; 59: 35-40.
4. Drimer T, Shahal B, Barak Y. Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. Int Clin Psychopharmacol 2004; 19: 27-29.
5. Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005; 66: 9-13.
6. Baumann RJ, Fakhoury TA, Kustra RP, Vuong A, Hammer AE, Messenheimer JA. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy. Curr Med Res Opin 2007; 23: 2461-2465.
7. Devarajan S, Dursun SM. Aggression in dementia with lamotrigine treatment. Am J Psychiatry 2000; 157: 1178.
8. De León OA. Treatment of psychotic symptoms with lamotrigine in Alzheimer disease. J Clin Psychopharmacol 2004; 24: 232-233.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
10. Inagaki A, Inada T. Dose equivalence of psychotropic drugs. Part XVIII: dose equivalence of psychotropic drugs. Jpn J Psychopharmacol 2006; 9: 1443-1447 (in Japanese
11. Inagaki A, Inada T. Dose equivalence of psychotropic drugs. Part XXIII: dose equivalence of novel antipsychotics. Jpn J Psychopharmacol 2012; 15: 397-404 (in Japanese
12. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
13. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
14. Kimura T, Hayashida H, Miyauchi D, Takamatsu J. Drug-resistant dementia with Lewy bodies: case report of 3 patients showing good response to aripiprazole treatment. Clin Psychiatry 2010; 52: 575-582 (in Japanese
15. Kimura T, Takamatsu J. Pilot study of pharmacological treatment for frontotemporal dementia: risk of donepezil treatment for behavioral and psychological symptoms. Geriatr Gerontol Int 2013; 13: 506-507.
16. Kimura T, Takamatsu J. Two cases of Alzheimer's disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil. Neuropsychiatr Dis Treat 2013; 9: 49-53.
17. Suzuki H, Inoue Y, Mikami K, Gen K. The influence and changes in the dosages of concomitantly used psychotropic drugs associated with the discontinuation of donepezil in severe Alzheimer's disease with behavioral and psychological symptoms on dementia: a preliminary open-label trial. Ther Adv Psychopharmacol 2014; 4: 37-42.
18. Ng B, Camacho A, Bardwell W, Sewell DD. Lamotrigine for agitation in older patients with dementia. Int Psychogeriatr 2009; 21: 207-208.
19. Sultzer DL, Davis SM, Tariot PN etal. CATIE-AD Study Group. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry 2008; 165: 844-854.
20. Kudo T. The effect of mematine on BPSD. Jpn J Psychopharmacol 2012; 15: 53-58 (in Japanese
21. Rafaniello C, Lombardo F, Ferrajolo C etal. Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy. Eur J Clin Pharmacol 2014; 70: 187-195.
22. Inoue Y, Suzuki H, Otomo M, Gen K. Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients. Jpn J New Remedies Clin 2011; 60: 109-116 (in Japanese
23. Bowden CL, Calabrese JR, Sachs G etal. Lamictal 606 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400.
24. Calabrese JR, Bowden CL, Sachs G etal. Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64: 1013-1024.
25. Goodwin GM, Bowden CL, Calabrese JR etal. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432-441.
26. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005; 64: 1134-1138.